Revance Therapeutics Inc (RVNC)
3.15
-0.01
(-0.32%)
USD |
NASDAQ |
May 20, 16:00
3.15
0.00 (0.00%)
After-Hours: 17:08
Revance Therapeutics Profit Margin (Quarterly): -102.3% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -102.3% |
December 31, 2023 | -79.80% |
September 30, 2023 | -248.7% |
June 30, 2023 | -115.7% |
March 31, 2023 | -130.6% |
December 31, 2022 | -292.4% |
September 30, 2022 | -291.9% |
June 30, 2022 | -217.7% |
March 31, 2022 | -254.7% |
December 31, 2021 | -243.2% |
September 30, 2021 | -376.7% |
June 30, 2021 | -383.9% |
March 31, 2021 | -538.7% |
December 31, 2020 | -703.4% |
September 30, 2020 | -2.12K% |
June 30, 2020 | -20.26K% |
March 31, 2020 | -106.8K% |
December 31, 2019 | -50.93K% |
September 30, 2019 | -90.02K% |
June 30, 2019 | |
March 31, 2019 | -12.70K% |
December 31, 2018 | -8.34K% |
September 30, 2018 | -1.39K% |
Date | Value |
---|---|
June 30, 2018 | -4.97K% |
March 31, 2018 | -18.15K% |
December 31, 2017 | -97.05K% |
September 30, 2017 | -40.87K% |
June 30, 2017 | -35.83K% |
March 31, 2017 | -36.21K% |
December 31, 2016 | -35.74K% |
September 30, 2016 | -23.97K% |
June 30, 2016 | -32.80K% |
March 31, 2016 | -26.52K% |
December 31, 2015 | -29.46K% |
September 30, 2015 | -25.57K% |
June 30, 2015 | -22.41K% |
March 31, 2015 | -20.54K% |
December 31, 2014 | -18.95K% |
September 30, 2014 | -18.64K% |
June 30, 2014 | -17.74K% |
March 31, 2014 | -13.56K% |
December 31, 2013 | -3.26K% |
September 30, 2013 | -5.62K% |
June 30, 2013 | -15.77K% |
March 31, 2013 | -28.88K% |
December 31, 2012 | -9.32K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-106.8K%
Minimum
Mar 2020
-79.80%
Maximum
Dec 2023
-14.43K%
Average
-292.4%
Median
Dec 2022
Profit Margin (Quarterly) Benchmarks
AbbVie Inc | 11.12% |
Eli Lilly and Co | 25.58% |
Aquestive Therapeutics Inc | -106.4% |
Humacyte Inc | -- |
AN2 Therapeutics Inc | -- |
Profit Margin (Quarterly) Related Metrics
Return on Assets | -59.54% |
Return on Invested Capital | -93.81% |
Gross Profit Margin (Quarterly) | 71.29% |
Operating Margin (Quarterly) | -90.16% |
Return on Net Operating Assets | -160.4% |